Skip to main content
Log in

Indomethacin versus meloxicam for prevention of heterotopic ossification after total hip arthroplasty

  • Original Article
  • Published:
Archives of Orthopaedic and Trauma Surgery Aims and scope Submit manuscript

Abstract

Background

Heterotopic ossification (HO) is a recognized postsurgical complication after total hip arthroplasty. Brooker et al. [6] established a grading system to define the degree of HO. The results of several studies have shown that non-steroidal anti-inflammatory drugs (NSAID) and radiation therapy reliably reduce the occurrence of severe HO. The exact cause and mechanism of bone formation are not known. The efficacy of indomethacin versus meloxicam for the prevention of heterotopic periarticular ossification and clinical NSAID side-effects after primary, cementless total hip arthroplasty was evaluated.

Methods

Probands underwent cementless total hip replacements at the Orthopaedic Department, Hospital Wiener Neustadt, from January 1997 to January 1998, did not take NSAID up to 4 weeks preoperatively and had no NSAID contraindications. Patients were separated into two groups by different hospitalisation floors. All patients selected for this study suffered from primary or secondary coxarthrosis. Data were collected as a prospective, randomised, parallel group study. Patients were given 50 mg indomethacin 2 times daily (n=58) vs 7.5 mg meloxicam (n=58) in a 12-day treatment course.

Results

A two-sided Cochran-Armitage trend test showed no statistically significant difference (p<0.05) for one of the drugs regarding influence on ectopic bone formation according to the grading system of Brooker et al.

Conclusion

Our study demonstrates that there is no statistically significant trend that indomethacin or meloxicam protects a hip arthroplasty better from heterotopic bone formation. We prefer indomethacin therapy because it is almost half the price of meloxicam therapy, and we recommend indomethacin in a 12-day treatment course given 50 mg 2 times daily as an effective, inexpensive and easily administered HO prophylaxis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1.

Similar content being viewed by others

References

  1. Arcq M (1973) Die paraartikulären Ossifikationen—eine Komplikation der Totalendoprothese des Hüftgelenkes. Arch Orthop 77:108–131

    CAS  Google Scholar 

  2. Barner A (1996) Review of clinical trials and benefit/risk ratio of meloxicam. Scand J Rheumatol 25 [Suppl 102]:29–37

    Google Scholar 

  3. Bengt IE et al (1991) Prevention of deep vein thrombosis and pulmonary embolism after total hip replacement. J Bone Joint Surg Am 73:484–493

    PubMed  Google Scholar 

  4. Braun K (1999) Präopertive Radiatio zur Prophylaxe heterotoper Ossifikationen nach endoprothetischem Hüftgelenkersatz. Z Orthop 137:22–23

    Google Scholar 

  5. Bremen-Kühne R v et al (1997) Indomethacin—Kurzzeittherapie vs Einzeitige low-dose-radiatio zur Prophylaxe perirtkulärer Ossifikationen (PAO) nach HTEP. Z Orthop 135:422–429

    PubMed  Google Scholar 

  6. Brooker AF et al (1973) Ectopic ossification following total hip replacement. J Bone Joint Surg Am 55:1629–1632

    CAS  PubMed  Google Scholar 

  7. Brückl R, Frey M (1997) Prophylaxe paraartikulärer Ossifikation durch Strahlentherapie nach zementloser Hüft-TEP-Implantation. Z Orthop 135:430–433

    PubMed  Google Scholar 

  8. DeLee J, Ferrari A, Charnley J (1976) Ectopic bone formation following low friction arthroplasty of the hip. Clin Orthop 121:53–59

    Google Scholar 

  9. Dequecker J et al (1998) Improvement in gastrointestinal tolerability the selective cyclooxigenase (COX)-2 inhibitor, meloxicam, compared with piroxicam: results of the safety and efficacy large-scale evaluation of COX-inhibiting therapies (SELECT) trial in osteoarthritis. Br J Rheumatol 37:946–951

    CAS  PubMed  Google Scholar 

  10. Dorn U et al (1998) Indomethacin for prevention of heterotopic ossification after hip arthroplasty. Acta Orthop Scand 69:107–110

    CAS  PubMed  Google Scholar 

  11. Drees P (1999) Das Risiko periartikulärer Ossifikationen beim Hüftgelenkersatz. Z Orthop 137:16–17

    Google Scholar 

  12. Emery P (1996) Clinical implications of selective cyclooxygenase-2 inhibition. Scand J Rheumatol 25 [Suppl 102]:23–28

    Google Scholar 

  13. Fröhling MA (1998) Periartikuläre heterotope Ossifikationen nach Hüft-TEP—Ein Impingement des Hüftgelenkes. Z Orthop 136:A54

    Google Scholar 

  14. Gebuhr P et al (1997) Naproxen given to prevent heterotopic ossification does not increase prosthetic loosening. Orthopaedics 5:21–23

    Google Scholar 

  15. Gierse H et al (1997) Zur Prophylaxe von periartikulären Vernöcherungen—mit Ergebnissen einer randomisierten, doppelblinden Studie zum Vergleich von Acemetacin versus Indometacin. Z Orthop 135:417–421

    CAS  PubMed  Google Scholar 

  16. Goldmann AR et al (1993) Strahlentherapie zur Prophylaxe von periartkulären, heterotopen Ossifikationen nach Implantation von HTEP. Z Orthop 131:151–155

    CAS  PubMed  Google Scholar 

  17. Hawkey C et al (1998) Gastrointestinal tolerability of the COX-2 inhibitor, meloxicam, in osteoarthritis patients: the meloxicam large scale international study safety asesment (MELISSA). Br J Rhreumatol 37:937–945

    Article  CAS  Google Scholar 

  18. Heyd R et al (1995) Die postoperative, konventionelle fraktionierte Strahlentherapie zur Prävention heterotoper Ossifikationen nach TEP des Hüftgelenks. Röntgenpraxis 48:233–237

    Google Scholar 

  19. Jockheck M et al (1998) Prevention of periarticular heterotopic ossification after endoprosthetic hip joint replacement by means of diclofenac. Arch Orthop Trauma Surg 117:337–340

    Article  CAS  PubMed  Google Scholar 

  20. Kienapfel H et al (1999) Prevention of heterotopic bone formation after total hip arthroplasty: a prospective randomised study comparing postoperative radiation therapy with indomethacin medication. Arch Orthop Trauma Surg 119:296–302

    Google Scholar 

  21. Knelles D et al (1997) Prevention of heterotopic ossification after total hip replacement. J Bone Joint Surg Br 79:596–602

    CAS  PubMed  Google Scholar 

  22. Koorevaar CT et al (1999) No effective prophylaxis of heterotopic ossification with short-term ibuprofen. Arch Orthop Trauma Surg 119:183–185

    Article  CAS  PubMed  Google Scholar 

  23. Lockie LM (1986) Tolerability and efficacy of long-term daily administration of indomethacin for moderate to severe chronic arthritic disorders. Clin Ther 8:398–405

    CAS  PubMed  Google Scholar 

  24. Moore K D et al (1998) Indomethacin versus radiation therapy for prophylaxis against heterotopic ossification in acetabular fractures. J Bone Joint Surg Br 80:259–263

    CAS  PubMed  Google Scholar 

  25. Nilsson OS (1998) Heterotopic ossification—editorial. Acta Orthop Scand 69:103–106

    Google Scholar 

  26. Noble S, Balfour JA (1996) Meloxicam. Drugs 51:424–432

    CAS  PubMed  Google Scholar 

  27. Patrignani P et al (1997) Differential inhibition of human protaglandin endoperoxide synthase-1 and -2 by nonsteroidal antiinflammatory drugs. J Physiol Pharmacol 48:623–631

    CAS  PubMed  Google Scholar 

  28. Peterson P-E et al (1998) Preventive effects of ibuprofen on periarticular heterotopic ossification after total hip arthroplasty. Acta Orthop Scand 69:111–115

    Google Scholar 

  29. Quack G et al (1998) Prä– versus postoperative Radiatio zur Prophylaxe von postoperativen Ossifikationen nach TEP. Z Orthop 136

  30. Ritter MA, Sieber JM (1985) Prophylactic indomethacin for prevention of heterotopic bone formation following total hip arthroplasty. Clin Orthop 196:217–225

    PubMed  Google Scholar 

  31. Schmidt SA et al (1988) The use of indomethacin to prevent the formation of heterotopic bone after total hip replacement. J Bone Joint Surg Am 70:834–838

    CAS  PubMed  Google Scholar 

  32. Sell S, Schleh T (1999) C-reactive protein as an early indicator of the formation of heterotopic ossifications after total hip replacement. Arch Orthop Trauma Surg 119:205–207

    Article  CAS  PubMed  Google Scholar 

  33. Van Leeuwen WM et al (1998) Preoperative irradiation for prophylaxis of ectopic ossification after hip arthroplasty. Acta Orthop Scand 69:116–118

    Google Scholar 

  34. Vane JR, Botting RM (1996) Mechanism of action of antiinflammatory drugs. Scand J Rheumatol 25 [Suppl 102]:9–21

    Google Scholar 

  35. Trnka H-J et al (1999) Stable bony integration with and without short term indomethacin prophylaxis. Arch Orthop Trauma Surg 119:456–460

    Article  CAS  Google Scholar 

Download references

Acknowledgements

Thanks to Mag. Thomas Lang, statistical consultant, Institute of Medical Statistics, University of Vienna, Schwarzspanierstrasse 17, 1090 Vienna, Austria. No grants were received for this study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Robert Legenstein.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Legenstein, R., Bösch, P. & Ungersböck, A. Indomethacin versus meloxicam for prevention of heterotopic ossification after total hip arthroplasty. Arch Orthop Trauma Surg 123, 91–94 (2003). https://doi.org/10.1007/s00402-003-0487-y

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00402-003-0487-y

Keywords

Navigation